S. Ilyas, A. Saeed, Q. Abbas et al.
Journal of Molecular Structure 1245 (2021) 130993
ꢀ
v/cm−1): 3325 (NH), 3185 (NH), 1659 (C=O), 1572, 1463 (C=C aro-
matic), 1230 (C=S); 1H NMR (CDCl3, 300 MHz,); δ (ppm): 12.16 (s,
1H, NH), 10.39 (s, 1H, NH), 7.29-7.44 (m, 4H, Ar–H), 7.35 (m, 4H,
Ar–H), 7.61 (d, 1H, J= 7.1 Hz, Ar–H), 2.33 (t, 2H, J= 2.3), 1.57 (q,
2H), 1.29 (m, 6H), 0.91 (t, 3H); 13C NMR (75 MHz CDCl3) δ (ppm)
180.8 (C=S), 174.8 (C=O), 138.5, 138.0, 135.6, 130.1, 128.9, 128.3,
128.2, 127.6, 127.5, 127.5, 127.3 (Aromatic-Cs), 35.8, 26.7, 21.8, 13.1
(n-heptyl, C).
N-([1,1 -Biphenyl]-2-ylcarbamothioyl)-2-bromobenzamide (3d)
Greyish black solid, m.p.= 188-
189 °C, Yield= 82 %, Rf = 0.40 (n-Hexane: Ethyl acetate 4:1); IR
(KBr, v/cm−1): 3315 (NH), 3105 (NH), 1651 (C=O), 1577, 1465 (C=C
aromatic), 1230 (C=S); 1H NMR (CDCl3, 300 MHz,); δ (ppm): 11.95
(s, 1H, NH), 9.43 (s, 1H, NH), 7.91 (d, 2H, J= 7.9 Hz, Ar–H), 7.76
(d, 2H, J= 7.5 Hz, Ar–H), 7.57-7.59 (m, 2H, Ar–H), 7.27-7.39 (m, 4H,
Ar–H), 7.33 (m, 4H, Ar–H), 7.12 (t, 1H, J= 2.1 Hz, Ar–H); 13C NMR
(75 MHz CDCl3); δ (ppm): 185.1 (C=S), 168.4 (C=O), 138.3, 138.1,
136.8, 135.5, 133.0, 131.8, 130.4, 130.2, 129.5, 128.7, 128.2, 128.0,
127.6, 127.4, 127.1, 126.8 (Aromatic-Cs).
ꢀ
N-([1,1 -Biphenyl]-2-ylcarbamothioyl)octanamide (3h)
Colorless crystals, m.p.= 123-125
°C, Yield= 82 %, Rf= 0.54 (n-Hexane: Ethyl acetate 4:1); IR (KBr)
v/cm−1): 3331 (NH), 3181 (NH), 1659 (C=O), 1580, 1470 (C=C aro-
matic), 1227 (C=S); 1H NMR (CDCl3, 300 MHz,); δ (ppm): 12.19
(s, 1H, NH), 10.45 (s, 1H, NH), 7.29-7.41 (m, 4H, Ar–H), 7.33 (m,
4H, Ar–H), 7.60 (d, 1H, J= 7.1 Hz, Ar–H), 2.35 (t, 2H, J= 2.3), 1.18
(q, 2H), 1.62 (q, 2H), 1.31 (m, 6H) 0.89 (t, 3H, CH3); 13C NMR (75
MHz CDCl3) δ (ppm) 180.8 (C=S), 174.8 (C=O), 138.5, 138.0, 135.6,
130.1, 128.9, 128.3, 128.2, 127.6, 127.5, 127.5, 127.3 (Aromatic-Cs),
35.8, 26.7, 21.8, 13.1 (n-octyl, C).
ꢀ
N-([1,1 -Biphenyl]-2-ylcarbamothioyl)butyramide (3e)
Grey solid, m.p.= 95-97 °C, Yield=
85 %, Rf= 0.51 (n-Hexane: Ethyl acetate 4:1); IR (KBr, v/cm−1):
3325 (NH), 3179 (NH), 1681 (C=O), 1583, 1460 (C=C aromatic),
1229 (C=S); 1H NMR (CDCl3, 300 MHz,); δ (ppm): 12.12 (s, 1H,
NH), 10.37 (s, 1H, NH), 7.35-7.42 (m, 4H, Ar–H), 7.39 (m, 4H, Ar–
H), 7.79 (d, 1H, J= 7.1 Hz, Ar–H), 2.36 (t, 2H, J= 2.3), 2.26 (q, 2H),
0.97 (t, 3H); 13C NMR (75 MHz CDCl3) δ (ppm) 180.9 (C=S), 174.5
(C=O), 138.7, 138.2, 135.8, 135.5, 130.2, 128.5, 128.3, 128.2, 127.6,
127.5, 127.4 (Aromatic-Cs), 37.2, 24.4, 13.2 (n-butyl, C).
2.2- In vitro Methodology
2.2.1-Elastase inhibition assay
The elastase (from porcine pancreas) activity was determined
following previously revealed technique by [28-29] with few ad-
justments. To play out the restraint of elastase movement, the
measure of delivered p-nitroaniline, which was hydrolyzed from
the substrate (N-succinyl-Ala-Ala-Ala-p-nitroanilide) by elastase,
was dictated by estimating the absorbance at 410 nm. In detail,
0.8 mM arrangement of N-succinyl-Ala-Ala-Ala-p-nitroanilide was
set up in a 0.2 M Tris-HCl cushion (pH 8.0) and this support (130
μL) was added to the test (10 μL) in a 96 well microplate. The
ꢀ
N-([1,1 -Biphenyl]-2-ylcarbamothioyl)pentanamide (3f)
microplate was pre-hatched for 10 min at 25 C before an elas-
º
tase (0.0375 Unit/mL) stock arrangement (10 μL) was added. Af-
ter catalyst expansion, the microplate was kept at 25 C for 30
º
min, and the absorbance was estimated at 410 nm utilizing mi-
croplate reader (SpectraMax ABS, USA). IC50 esteems were deter-
mined by nonlinear relapse utilizing GraphPad Prism 5.0 (Graph-
Pad, San Diego, CA USA). All tests were done in three-fold. The
elastase hindrance exercises were determined by the accompany-
ing recipe:
Colorless crystals, m.p.= 103-104
°C, Yield= 80 %, Rf= 0.53 (n-Hexane: Ethyl acetate 4:1); IR (KBr,
v/cm−1): 3321 (NH), 3187 (NH), 1685 (C=O), 1581, 1454 (C=C aro-
matic), 1224 (C=S); 1H NMR (CDCl3, 300 MHz,); δ (ppm): 12.14 (s,
1H, NH), 10.38 (s, 1H, NH), 7.36-7.45 (m, 4H, Ar–H), 7.40 (m, 4H,
Ar–H), 7.81 (d, 1H, J= 7.1 Hz, Ar–H), 2.46 (t, 2H, J= 2.3), 1.57 (q,
2H), 1.33 (q, 2H), 0.90 (t, 3H); 13C NMR (75 MHz CDCl3) δ (ppm)
180.8 (C=S), 174.8 (C=O), 138.5, 138.0, 135.6, 130.1, 128.9, 128.3,
128.2, 127.6, 127.5, 127.5, 127.3 (Aromatic-Cs), 35.8, 26.7, 21.8, 13.1
(n-pentyl, C).
ꢀ
ꢁ
Elastase inhibition activity
%
( )
=
ODcontrol − ODsample × 100 /ODcontrol
Where ODcontrol and ODsample signifies the optical densities in
the lack and existence of sample, respectively. Oleanolic acid was
used as the standard inhibitor for elastase.
ꢀ
N-([1,1 -Biphenyl]-2-ylcarbamothioyl)heptanamide (3g)
2.2.2-Protocol for Kinetics
Kinetic analysis was carried out to determine the mode of inhi-
bition by following our optimized method [30]. The compound 3c
was selected on the basis of its high IC50 value. Kinetics were car-
ried out by varying the concentration of N-succinyl-Ala-Ala-Ala-p-
nitroanilide from 2, 1, 0.5, 0.25, 0.125 and 0.0625 mM in the pres-
ence of different concentrations of compound 3c (0.00, 0.25 and
0.51 μM) following the same procedure for the kinetic study as
described in elastase inhibition assay protocol. Maximal initial ve-
locities were determined from initial linear portion of absorbances
Colorless crystals, m.p.= 115-117
°C, Yield= 82 %, Rf= 0.54 (n-Hexane: Ethyl acetate 4:1); IR (KBr,
3